PLATO bleeding criteria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Undo revision 865191 by Kalsang Dolma (talk)) |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==PLATO | ==Overview== | ||
'''PLATO bleeding classification''' <ref name="pmid15842354">{{cite journal| author=Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis| title=Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. | journal=J Thromb Haemost | year= 2005 | volume= 3 | issue= 4 | pages= 692-4 | pmid=15842354 | doi=10.1111/j.1538-7836.2005.01204.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15842354 }} </ref> | |||
{{cquote| | {{cquote| | ||
===1. Major Life- | ===1. Major Life-threatening:=== | ||
*Fatal | *Fatal | ||
*[[Intracranial hemorrhage|Intracranial]] | *[[Intracranial hemorrhage|Intracranial]] | ||
Line 20: | Line 21: | ||
*Requiring transfusion of 2 to 3 U whole blood or PRBCs | *Requiring transfusion of 2 to 3 U whole blood or PRBCs | ||
=====Any Major===== | |||
*Any one of the above criteria | *Any one of the above criteria | ||
Revision as of 17:39, 27 March 2013
Bleeding Microchapters |
Treatment |
---|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
Perioperative Bleeding |
PLATO bleeding criteria On the Web |
American Roentgen Ray Society Images of PLATO bleeding criteria |
Risk calculators and risk factors for PLATO bleeding criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
PLATO bleeding classification [1]
“ |
1. Major Life-threatening:
Other Major
Any Major
2. Minor
3. Minimal
|
” |
References
- ↑ Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005). "Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients". J Thromb Haemost. 3 (4): 692–4. doi:10.1111/j.1538-7836.2005.01204.x. PMID 15842354.